Maricann Group (MARI) Stock Price, News & Analysis

Company Overview

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company's services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 682,578 shs
• Average Volume: 142,686 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $13.90
• Consensus Rating: Buy

MARI Stock Analysis - Frequently Asked Questions

How do I buy shares of Maricann Group?

Shares of MARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Maricann Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Maricann Group investors own include Aurora Cannabis (ACB), VIVO Cannabis (ABCN), Aphria (APHA), Suncor Energy (SU), Suncor Energy (SU), CV Sciences (CVSI) and Canopy Growth (WEED).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: CNSX:MARI
• CIK: N/A
• Web: www.maricann.com
• Phone: +1-289-2886284
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Maricann Group: $13.90
• High Price Target: $16.00
• Low Price Target: $11.50
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A